Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Dick

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Clinical & Experimental Ophthalmology|January 27, 2005
Are we still reluctant to immunosuppress?Andrew D Dick
Investigative Ophthalmology & Visual Science|August 19, 2015
Enhancing Inflammation as an Adjuvant to Neovascular AMD TherapyAndrew D Dick
Ocular Immunology and Inflammation|August 3, 2022
PerspectiveAndrew D Dick
Ophthalmic Research|March 9, 2012
Road to fulfilment: taming the immune response to restore visionAndrew D Dick
Expert Opinion on Investigational Drugs|January 9, 2003
Recent developments in the pharmacological treatment and prevention of corneal graft rejectionSanjiv Banerjee, Andrew D Dick
JAMA|November 10, 2025
Review on Uveitis-ReplyPanayiotis Maghsoudlou, Andrew D Dick
Ocular Immunology and Inflammation|October 30, 2004
Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis ratsDebatri Banerjee, Andrew D Dick
The Practitioner|October 28, 2006
Diagnose loss of visionSanjiv Banerjee, Andrew D Dick
The British Journal of Ophthalmology|June 19, 2003
Responding to readers' and authors' needsAndrew D Dick, Creig Hoyt
Current Opinion in Ophthalmology|December 29, 2007
Biologics in the treatment of uveitisFraser R Imrie, Andrew D Dick
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Clinical & Experimental Ophthalmology|January 27, 2005
Are we still reluctant to immunosuppress?Andrew D Dick
Investigative Ophthalmology & Visual Science|August 19, 2015
Enhancing Inflammation as an Adjuvant to Neovascular AMD TherapyAndrew D Dick
Ocular Immunology and Inflammation|August 3, 2022
PerspectiveAndrew D Dick
Ophthalmic Research|March 9, 2012
Road to fulfilment: taming the immune response to restore visionAndrew D Dick
Expert Opinion on Investigational Drugs|January 9, 2003
Recent developments in the pharmacological treatment and prevention of corneal graft rejectionSanjiv Banerjee, Andrew D Dick
JAMA|November 10, 2025
Review on Uveitis-ReplyPanayiotis Maghsoudlou, Andrew D Dick
Ocular Immunology and Inflammation|October 30, 2004
Blocking CD200-CD200 receptor axis augments NOS-2 expression and aggravates experimental autoimmune uveoretinitis in Lewis ratsDebatri Banerjee, Andrew D Dick
The Practitioner|October 28, 2006
Diagnose loss of visionSanjiv Banerjee, Andrew D Dick
The British Journal of Ophthalmology|June 19, 2003
Responding to readers' and authors' needsAndrew D Dick, Creig Hoyt
Current Opinion in Ophthalmology|December 29, 2007
Biologics in the treatment of uveitisFraser R Imrie, Andrew D Dick
Pageof 25